Cargando…

A Generic Strategy to Generate Bifunctional Two-in-One Antibodies by Chicken Immunization

Various formats of bispecific antibodies exist, among them Two-in-One antibodies in which each Fab arm can bind to two different antigens. Their IgG-like architecture accounts for low immunogenicity and also circumvents laborious engineering and purification steps to facilitate correct chain pairing...

Descripción completa

Detalles Bibliográficos
Autores principales: Harwardt, Julia, Bogen, Jan P., Carrara, Stefania C., Ulitzka, Michael, Grzeschik, Julius, Hock, Björn, Kolmar, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036444/
https://www.ncbi.nlm.nih.gov/pubmed/35479092
http://dx.doi.org/10.3389/fimmu.2022.888838
_version_ 1784693524271202304
author Harwardt, Julia
Bogen, Jan P.
Carrara, Stefania C.
Ulitzka, Michael
Grzeschik, Julius
Hock, Björn
Kolmar, Harald
author_facet Harwardt, Julia
Bogen, Jan P.
Carrara, Stefania C.
Ulitzka, Michael
Grzeschik, Julius
Hock, Björn
Kolmar, Harald
author_sort Harwardt, Julia
collection PubMed
description Various formats of bispecific antibodies exist, among them Two-in-One antibodies in which each Fab arm can bind to two different antigens. Their IgG-like architecture accounts for low immunogenicity and also circumvents laborious engineering and purification steps to facilitate correct chain pairing. Here we report for the first time the identification of a Two‐in‐One antibody by yeast surface display (YSD) screening of chicken-derived immune libraries. The resulting antibody simultaneously targets the epidermal growth factor receptor (EGFR) and programmed death‐ligand 1 (PD-L1) at the same Fv fragment with two non-overlapping paratopes. The dual action Fab is capable of inhibiting EGFR signaling by binding to dimerization domain II as well as blocking the PD-1/PD-L1 interaction. Furthermore, the Two-in-One antibody demonstrates specific cellular binding properties on EGFR/PD-L1 double positive tumor cells. The presented strategy relies solely on screening of combinational immune-libraries and obviates the need for any additional CDR engineering as described in previous reports. Therefore, this study paves the way for further development of therapeutic antibodies derived from avian immunization with novel and tailor-made binding properties.
format Online
Article
Text
id pubmed-9036444
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90364442022-04-26 A Generic Strategy to Generate Bifunctional Two-in-One Antibodies by Chicken Immunization Harwardt, Julia Bogen, Jan P. Carrara, Stefania C. Ulitzka, Michael Grzeschik, Julius Hock, Björn Kolmar, Harald Front Immunol Immunology Various formats of bispecific antibodies exist, among them Two-in-One antibodies in which each Fab arm can bind to two different antigens. Their IgG-like architecture accounts for low immunogenicity and also circumvents laborious engineering and purification steps to facilitate correct chain pairing. Here we report for the first time the identification of a Two‐in‐One antibody by yeast surface display (YSD) screening of chicken-derived immune libraries. The resulting antibody simultaneously targets the epidermal growth factor receptor (EGFR) and programmed death‐ligand 1 (PD-L1) at the same Fv fragment with two non-overlapping paratopes. The dual action Fab is capable of inhibiting EGFR signaling by binding to dimerization domain II as well as blocking the PD-1/PD-L1 interaction. Furthermore, the Two-in-One antibody demonstrates specific cellular binding properties on EGFR/PD-L1 double positive tumor cells. The presented strategy relies solely on screening of combinational immune-libraries and obviates the need for any additional CDR engineering as described in previous reports. Therefore, this study paves the way for further development of therapeutic antibodies derived from avian immunization with novel and tailor-made binding properties. Frontiers Media S.A. 2022-04-11 /pmc/articles/PMC9036444/ /pubmed/35479092 http://dx.doi.org/10.3389/fimmu.2022.888838 Text en Copyright © 2022 Harwardt, Bogen, Carrara, Ulitzka, Grzeschik, Hock and Kolmar https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Harwardt, Julia
Bogen, Jan P.
Carrara, Stefania C.
Ulitzka, Michael
Grzeschik, Julius
Hock, Björn
Kolmar, Harald
A Generic Strategy to Generate Bifunctional Two-in-One Antibodies by Chicken Immunization
title A Generic Strategy to Generate Bifunctional Two-in-One Antibodies by Chicken Immunization
title_full A Generic Strategy to Generate Bifunctional Two-in-One Antibodies by Chicken Immunization
title_fullStr A Generic Strategy to Generate Bifunctional Two-in-One Antibodies by Chicken Immunization
title_full_unstemmed A Generic Strategy to Generate Bifunctional Two-in-One Antibodies by Chicken Immunization
title_short A Generic Strategy to Generate Bifunctional Two-in-One Antibodies by Chicken Immunization
title_sort generic strategy to generate bifunctional two-in-one antibodies by chicken immunization
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036444/
https://www.ncbi.nlm.nih.gov/pubmed/35479092
http://dx.doi.org/10.3389/fimmu.2022.888838
work_keys_str_mv AT harwardtjulia agenericstrategytogeneratebifunctionaltwoinoneantibodiesbychickenimmunization
AT bogenjanp agenericstrategytogeneratebifunctionaltwoinoneantibodiesbychickenimmunization
AT carrarastefaniac agenericstrategytogeneratebifunctionaltwoinoneantibodiesbychickenimmunization
AT ulitzkamichael agenericstrategytogeneratebifunctionaltwoinoneantibodiesbychickenimmunization
AT grzeschikjulius agenericstrategytogeneratebifunctionaltwoinoneantibodiesbychickenimmunization
AT hockbjorn agenericstrategytogeneratebifunctionaltwoinoneantibodiesbychickenimmunization
AT kolmarharald agenericstrategytogeneratebifunctionaltwoinoneantibodiesbychickenimmunization
AT harwardtjulia genericstrategytogeneratebifunctionaltwoinoneantibodiesbychickenimmunization
AT bogenjanp genericstrategytogeneratebifunctionaltwoinoneantibodiesbychickenimmunization
AT carrarastefaniac genericstrategytogeneratebifunctionaltwoinoneantibodiesbychickenimmunization
AT ulitzkamichael genericstrategytogeneratebifunctionaltwoinoneantibodiesbychickenimmunization
AT grzeschikjulius genericstrategytogeneratebifunctionaltwoinoneantibodiesbychickenimmunization
AT hockbjorn genericstrategytogeneratebifunctionaltwoinoneantibodiesbychickenimmunization
AT kolmarharald genericstrategytogeneratebifunctionaltwoinoneantibodiesbychickenimmunization